Skip to content

Improving Radon Education and Awareness in Cancer Patients and Their Extended Community

Improving Radon Education and Awareness in Cancer Patients and Their Extended Community

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07712133
Enrollment
200
Registered
2026-07-17
Start date
2026-08-01
Completion date
2028-06-01
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivorship

Brief summary

Clinical appointments are an opportunity to provide cancer survivors (defined as patients and survivors) and people in their communities (e.g. caregivers, family members, friends) with education about radon and radon testing. This is a pilot study to develop and evaluate the impact of a clinic-based intervention that educates cancer survivors and their caregivers/families about radon and radon testing. This study will enroll survivors, caregivers, and interested family members or friends in this intervention because they are important decision-makers with respect to the survivors' cancer care and well-being. This intervention would occur in clinics that treat lung cancer as well as clinics that treat cancers for which radon is being investigated as a contributor to their etiology (e.g. breast, skin melanoma, gastrointestinal).

Interventions

BEHAVIORALEducational Presentation

A study staff member will deliver a short educational intervention about radon via PowerPoint with a standardized script to participants. The intervention can be delivered online or in person. If in person, the caregiver and patient will listen to the presentation given by the study team member. If done online, the presentation will be conducted by a study team member using secured video conference software (e.g. Zoom, Teams).

Sponsors

University of Utah
Lead SponsorOTHER
Huntsman Cancer Institute
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult age 18 or older * Patient of HCI or friend/family or caregiver of patient of HCI (eligible if living in same home or different homes) * Resident of Utah, Wyoming, Idaho, Montana, or Nevada * Able to provide consent

Exclusion criteria

* Below age 18 * Resident of a state other than Utah, Wyoming, Idaho, Montana, or Nevada * Not able to provide consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Radon Knowledgeup to 1 dayTo compare participants' pre- and post-intervention knowledge about radon based on demographics and estimated residential radon levels. Radon knowledge will be assessed using a questionnaire with total scores ranging from 0 to 5, where higher scores indicate greater radon knowledge and lower scores indicate less radon knowledge.

Secondary

MeasureTime frameDescription
Proportion of Participants that Test for Radonup to 4 weeksTo identify the proportion of participants that test for radon after the intervention according to demographics, estimated residential radon levels, and offered financial incentive.

Countries

United States

Contacts

CONTACTKathryn Weaver
kathryn.weaver@hci.utah.edu801-646-4458
PRINCIPAL_INVESTIGATORJudy Ou, PhD

Huntsman Cancer Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026